What to expect when you take Suboxone

What to expect when you take Suboxone

Summary

Suboxone (buprenorphine/naloxone) is one of the most effective treatments for opioid use disorder. It reduces cravings, prevents withdrawal, stabilizes your brain chemistry, and dramatically lowers your risk of overdose. This guide explains everything you can expect.

How Suboxone Works: What to Expect in the First Days and Weeks

A clear, supportive guide to understanding your medication

NOTE: The below is intended as general information and not personalized medical guidance. If you have specific questions about your case, speak with a licensed medical provider, such as Affect.


💬 Quick Overview

Suboxone (buprenorphine/naloxone) is one of the most effective treatments for opioid use disorder. It reduces cravings, minimizes withdrawal, stabilizes your brain chemistry, and dramatically lowers your risk of overdose.

But people often have questions:

  • Why does Suboxone help me feel normal?

  • Why did I feel sick the first time I took it?

  • How long before it starts working fully?

  • What should I expect in the first month?

Here’s the truth backed by decades of medical research:
👉 Suboxone stabilizes withdrawal, cravings, and mood by gently activating opioid receptors.
👉 Mild early discomfort is common but usually improves within a week.
👉 At the right dose, it helps you feel normal—not high—and supports long-term recovery.

This guide explains everything in clear, simple language.


🧠 How Suboxone Actually Works

Suboxone contains buprenorphine, a medication that attaches to the same receptors in your brain that opioids do — but with a gentler, safer effect.

Here’s why it works:

1. It sticks to your opioid receptors extremely well.

Buprenorphine binds tightly, which:

  • stops withdrawal

  • blocks other opioids

  • smooths out mood and cravings

2. It only activates the receptors partway.

This is called a partial agonist effect.

👉 You feel normal — not high, not sedated, not sick.

3. It has a “ceiling effect.”

After a certain point, taking more won’t make you feel stronger effects or get you “high.”
This makes overdosing on Suboxone alone extremely unlikely (Walsh & Eissenberg, 2003).

4. The naloxone part is just for safety.

When taken under the tongue as directed:

  • naloxone is minimally absorbed

  • it does not cause withdrawal

  • it does not block the buprenorphine

It’s there to prevent misuse by injection — not to interfere with your treatment.


🟩 Why People Feel Sick the First Time They Take Suboxone

Feeling sick after the first dose happens for two main reasons:


1. It was taken too early

If opioids are still on your receptors, Suboxone “pushes them off” too suddenly → precipitated withdrawal.

This is the number-one cause of early nausea, sweating, shaking, or feeling terrible.


2. Your body is adjusting

Even when started perfectly, your brain and nervous system take 24–72 hours to stabilize.

During this adjustment period you may feel:

  • headache

  • mild nausea

  • dizziness

  • mild anxiety

  • sweating

  • fatigue

These usually fade as your dose stabilizes.


💡 Good news:

Feeling sick at first does not mean Suboxone isn’t right for you.
It usually means the timing or dose needs to be adjusted.

Your provider can help with this quickly.


What to Expect on Suboxone: Day 1 to Day 30

🟨 Day 1–3: Stabilization Phase

You may experience:

  • mild headache or nausea

  • sleepiness or restlessness

  • sweating

  • low energy

  • weird dreams

  • emotional ups-and-downs

These are normal as your body balances out.

Most patients feel significantly better by Day 3–5.


🟦 Day 4–14: Cravings Drop & Mood Stabilizes

Most people report:

  • cravings decreasing or disappearing

  • motivation returning

  • improved sleep

  • better energy

If you still have withdrawal symptoms, you may need a slightly higher dose.


🟩 Week 2–4: Feeling “Like Yourself Again”

This is when Suboxone’s full benefits show up:

  • stable mood

  • balanced energy

  • no highs or lows

  • almost no cravings

  • mental clarity

Many people describe it as “living in color again” after months or years in survival mode.


🔄 Why Do Some People Still Crave on Suboxone?

Cravings usually drop dramatically, but you may still feel them if:

  • your dose is too low

  • you’re under stress

  • you have untreated depression/anxiety

  • triggers are active in your environment

These cravings are not a sign that MAT isn’t working — they’re a sign your treatment plan may need adjustment.

Your provider can modify:

  • dose

  • medication timing

  • comfort meds

  • therapy support

  • coping tools

Cravings should improve with the right dose.


Is Suboxone “Trading One Addiction for Another”?

No.
This is a stigma-based myth.

Here’s the medical distinction:

Addiction = loss of control, cravings, compulsive use, and harm.

MAT = stability, normal functioning, safety, and reduced cravings.

With Suboxone:

  • you don’t get high

  • you don’t feel impaired

  • you don’t experience compulsive use

  • you regain control of your life

MAT is treatment — not addiction.


Is It Safe to Take Suboxone Long-Term?

Yes.
Long-term MAT is one of the most protective factors against overdose and relapse.

People who stay on Suboxone for 12 months or longer have:

  • far fewer relapses

  • lower overdose risk

  • more stable recovery

  • better employment rates

  • improved mental health
    (ASAM, 2020)

You can taper later — when you’re stable, supported, and ready.


🧭 Your Suboxone Expectations Checklist

✔ Expect some mild symptoms in the first 1–3 days

✔ Expect cravings to drop dramatically in the first week

✔ Expect mood and sleep to stabilize in weeks 2–4

✔ Expect to feel normal, not high

✔ Expect to adjust your dose with your provider

✔ Expect long-term treatment to be safe and effective

✔ Expect Suboxone to protect you from overdose and relapse

This is what recovery is supposed to feel like.


📘 Citations

American Society of Addiction Medicine. (2020). National practice guideline for the treatment of opioid use disorder.

Hämmig, R., et al. (2016). Buprenorphine induction best practices. European Addiction Research, 22(3).

SAMHSA. (2021). TIP 63: Medications for Opioid Use Disorder.

Strain, E. C., & Walsh, S. L. (2019). Buprenorphine’s pharmacology and ceiling effect. The Lancet Psychiatry.

Walsh, S. L., & Eissenberg, T. (2003). The clinical pharmacology of buprenorphine. Drug and Alcohol Dependence.

2500 1667 Kristin Muhlner